$Iterum Therapeutics (ITRM.US)$ its almost bout time.
Therapeutics plc's (NASDAQ:ITRM)future prospects. Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. With the latest financial year loss of US$38m and a trailing-twelve-month loss of US$28m, the US$20m market-cap company alleviated its loss by moving closer towards its target of breakeven. The most pressing concern for investor...

$Iterum Therapeutics (ITRM.US)$ Monday they will have conference, so hold it? it gonna fly again with the PR on Monday?

$Iterum Therapeutics (ITRM.US)$ hold the line

$Iterum Therapeutics (ITRM.US)$ i have 15 k shares ready

$Biofrontera (BFRI.US)$
Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC
First Phase 3 PDT study in patients with sBCC in the United States.
Rigorous dual endpoints requiring complete clinical and cytological clearance of malignant lesions.
Data now being analyzed, interim results expected November 2024.
BCC is the most common skin cancer in the US with more than 3 million cases each year...